Khrom Capital Management LLC Acquires 202,448 Shares of Sotera Health Company $SHC

Key Points

• Khrom Capital Management LLC increased its stake in Sotera Health by 55.4%, acquiring an additional 202,448 shares, bringing its total holdings to 567,834 shares, valued at approximately $6.6 million.
• In insider trading news, Michael P. Rutz sold 126,611 shares at an average price of $16.38, leading to a 21.95% decrease in his ownership.
• Sotera Health's recent earnings report showed an EPS of $0.20, beating estimates, with revenue up 6.4% year-over-year, indicating positive financial momentum.

Khrom Capital Management LLC raised its holdings in shares of Sotera Health Company (NASDAQ:SHC - Free Report) by 55.4% during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 567,834 shares of the company's stock after purchasing an additional 202,448 shares during the period. Sotera Health accounts for approximately 0.9% of Khrom Capital Management LLC's holdings, making the stock its 14th biggest holding. Khrom Capital Management LLC owned about 0.20% of Sotera Health worth $6,621,000 at the end of the most recent quarter.

A number of other large investors also recently added to or reduced their stakes in the business. Sculptor Capital LP lifted its position in Sotera Health by 80.8% during the 1st quarter. Sculptor Capital LP now owns 9,037,511 shares of the company's stock valued at $105,377,000 after purchasing an additional 4,037,511 shares during the period. T. Rowe Price Investment Management Inc. lifted its position in Sotera Health by 5.9% during the 1st quarter. T. Rowe Price Investment Management Inc. now owns 8,045,502 shares of the company's stock valued at $93,811,000 after purchasing an additional 450,761 shares during the period. Dimensional Fund Advisors LP lifted its position in Sotera Health by 27.3% during the 4th quarter. Dimensional Fund Advisors LP now owns 3,143,955 shares of the company's stock valued at $43,004,000 after purchasing an additional 673,979 shares during the period. Irenic Capital Management LP lifted its position in Sotera Health by 4.3% during the 4th quarter. Irenic Capital Management LP now owns 2,909,163 shares of the company's stock valued at $39,797,000 after purchasing an additional 120,832 shares during the period. Finally, Two Seas Capital LP lifted its position in Sotera Health by 624.0% during the 4th quarter. Two Seas Capital LP now owns 2,896,136 shares of the company's stock valued at $39,619,000 after purchasing an additional 2,496,136 shares during the period. 91.03% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling

In related news, insider Michael P. Rutz sold 126,611 shares of the company's stock in a transaction that occurred on Friday, August 22nd. The stock was sold at an average price of $16.38, for a total value of $2,073,888.18. Following the transaction, the insider owned 450,204 shares in the company, valued at approximately $7,374,341.52. This represents a 21.95% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Insiders own 55.12% of the company's stock.

Wall Street Analyst Weigh In

A number of research firms have recently weighed in on SHC. Wall Street Zen raised Sotera Health from a "buy" rating to a "strong-buy" rating in a research note on Saturday, August 16th. Barclays reaffirmed an "overweight" rating on shares of Sotera Health in a research note on Friday, August 8th. Finally, The Goldman Sachs Group raised Sotera Health from a "neutral" rating to a "buy" rating and increased their target price for the stock from $14.00 to $17.00 in a research note on Monday, May 5th. Four analysts have rated the stock with a Buy rating and one has given a Hold rating to the company's stock. Based on data from MarketBeat.com, Sotera Health currently has an average rating of "Moderate Buy" and an average price target of $16.00.

Sotera Health Price Performance

Shares of SHC traded down $0.21 during trading hours on Tuesday, reaching $16.16. The stock had a trading volume of 1,396,244 shares, compared to its average volume of 1,718,861. Sotera Health Company has a 12 month low of $9.53 and a 12 month high of $17.08. The stock has a market capitalization of $4.59 billion, a PE ratio of 202.03 and a beta of 1.84. The company has a debt-to-equity ratio of 4.49, a quick ratio of 2.23 and a current ratio of 2.47. The company's 50-day moving average is $13.08 and its two-hundred day moving average is $12.30.

Sotera Health (NASDAQ:SHC - Get Free Report) last issued its quarterly earnings results on Friday, August 8th. The company reported $0.20 earnings per share for the quarter, topping analysts' consensus estimates of $0.17 by $0.03. Sotera Health had a return on equity of 39.42% and a net margin of 2.14%.The firm had revenue of $294.34 million during the quarter, compared to the consensus estimate of $275.81 million. During the same period last year, the business posted $0.19 EPS. The business's revenue was up 6.4% compared to the same quarter last year. Sotera Health has set its FY 2025 guidance at 0.750-0.820 EPS. Research analysts expect that Sotera Health Company will post 0.61 EPS for the current year.

Sotera Health Company Profile

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.